CVRx (CVRX) Equity Ratio (2020 - 2026)
CVRx's quarterly Equity Ratio came in at 0.29 in Q1 2026, down 45.47% year-on-year from 0.54 in Q1 2025, and down 22.22% quarter-over-quarter from 0.38 in Q4 2025.
CVRx has reported Equity Ratio for 7 years, with the latest figure at 0.29 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio fell 45.47% year-over-year to 0.29; the trailing twelve-month figure through Mar 2026 stood at 0.29 (down 45.47% YoY), and the FY2025 full-year result was 0.38, down 29.54% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.29, down from 0.38 in the prior quarter.
- The five-year high for Equity Ratio was 0.95 in Q2 2022, with the low at 0.29 in Q1 2026.
- Average Equity Ratio over 5 years is 0.65, with a median of 0.62 recorded in 2024.
- Year-over-year, Equity Ratio soared 116.38% in 2022 and tumbled 45.47% in 2026.
- Tracing CVRX's Equity Ratio over 5 years: stood at 0.87 in 2022, then declined by 24.58% to 0.66 in 2023, then declined by 19.19% to 0.53 in 2024, then slipped by 29.54% to 0.38 in 2025, then declined by 22.22% to 0.29 in 2026.
- The last three Equity Ratio figures came in at 0.29 (Q1 2026), 0.38 (Q4 2025), and 0.43 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | CVRx | 144.43 Mn | 72.13 Mn | 12.88 Mn | 0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.29 |
| Dec 31, 2025 | 0.38 |
| Sep 30, 2025 | 0.43 |
| Jun 30, 2025 | 0.48 |
| Mar 31, 2025 | 0.54 |
| Dec 31, 2024 | 0.53 |
| Sep 30, 2024 | 0.51 |
| Jun 30, 2024 | 0.58 |
| Mar 31, 2024 | 0.62 |
| Dec 31, 2023 | 0.66 |
| Sep 30, 2023 | 0.78 |
| Jun 30, 2023 | 0.78 |
| Mar 31, 2023 | 0.81 |
| Dec 31, 2022 | 0.87 |
| Sep 30, 2022 | 0.93 |
| Jun 30, 2022 | 0.95 |
| Mar 31, 2022 | 0.95 |
| Dec 31, 2021 | 0.96 |
| Sep 30, 2021 | 0.86 |
| Jun 30, 2021 | -5.79 |
| Dec 31, 2020 | -4.53 |